Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03871075 · ClinicalTrials.gov registry record · NA
Intermittent Pneumatic Compression With and Without Exercise to Improve Functioning in Peripheral Artery Disease
A NA study of Peripheral Artery Disease, sponsored by Northwestern University.
- Recruiting
- Registry status
- NA
- Development phase
- 230
- Enrollment target
- 4
- Study locations
NCT03871075 is a NA study of Peripheral Artery Disease that is actively recruiting participants, run by Northwestern University. The registered enrollment target is 230 participants, above the 122-participant average among 50 other Peripheral Artery Disease trials with a reported enrollment target (89% higher). The trial reports 4 study locations across 3 states.
The verdict
NCT03871075, a NA study of Peripheral Artery Disease, is actively recruiting participants, sponsored by Northwestern University.
- RECRUITING
- Registry status
- NA
- Development phase
- 230 participants
- Enrollment target
- 4
- Study locations
Study Summary
The INTERCEDE randomized trial will establish whether six-months of intermittent pneumatic compression combined with walking exercise improves walking endurance at six-month follow-up, compared to walking exercise + sham compression therapy, in people with lower extremity peripheral artery disease (PAD). The INTERCEDE trial will also determine whether intermittent pneumatic compression therapy improves walking endurance at 6-month follow-up, compared to a sham compression therapy. The trial will also determine whether benefits of intermittent pneumatic compression persist after intermittent pneumatic compression treatment is completed.
Conditions Studied
Interventions
- BEHAVIORAL Health Education
- DEVICE Sham device
- DEVICE intermittent pneumatic compression
- BEHAVIORAL exercise
Study Locations (4)
Illinois
- Northwestern University - Chicago
- University of Chicago - Chicago
Michigan
- Henry Ford Health - Detroit
Minnesota
- University of Minnesota - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 230 participants |
| Start Date | 2019-01-02 |
| Est. Completion | 2026-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03871075
The ClinicalTrials.gov registry entry for NCT03871075 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 230 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 122-participant average among 50 other Peripheral Artery Disease trials with a reported enrollment target (89% higher). The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Peripheral Artery Disease appearing as the primary indexed condition, and to 4 interventions - of which Health Education is the first listed.
NCT03871075 reports 4 study locations spanning 3 distinct geographic areas - top geographies include Illinois, Michigan, Minnesota.
Frequently Asked Questions
What is clinical trial NCT03871075 about?
NCT03871075 is a clinical study titled "Intermittent Pneumatic Compression With and Without Exercise to Improve Functioning in Peripheral Artery Disease". The INTERCEDE randomized trial will establish whether six-months of intermittent pneumatic compression combined with walking exercise improves walking endurance at six-month follow-up, compared to walking exercise + sham compression therapy, in people with lower extremity peripheral artery disease (...
What is the current status of trial NCT03871075?
This trial is currently recruiting. It is a NA study. The enrollment target is 230 participants. The study started on 2019-01-02. Estimated completion is 2026-11.
What conditions does trial NCT03871075 study?
This clinical trial studies the following conditions: Peripheral Artery Disease.
What interventions are being tested in trial NCT03871075?
The interventions under investigation include: Health Education (BEHAVIORAL), Sham device (DEVICE), intermittent pneumatic compression (DEVICE), exercise (BEHAVIORAL).
Who is sponsoring clinical trial NCT03871075?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03871075 being conducted?
This trial has 4 study locations across Illinois, Michigan, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Peripheral Artery Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The Effects of a Novel, Non-ischemic and Pain-free Exercise Intervention in Peripheral Artery Disease
RECRUITING · NA
-
BEETroot Juice to Reverse Functional Impairment in PAD
RECRUITING · NA
-
Telehealth Delivered Home-based Walking for Vets With Peripheral Artery Disease
RECRUITING · NA
-
The THOR IDE Study
RECRUITING · NA
-
Randomized Controlled Trial of Alert-Based Computerized Decision Support for Patients With Peripheral Artery Disease Not Prescribed Lipid-Lowering Therapy
RECRUITING · NA
-
Leg Heat Therapy in Peripheral Artery Disease
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.